These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28435061)

  • 1. Nanomedicine-mediated drug targeting of cancer stem cells.
    Singh D; Minz AP; Sahoo SK
    Drug Discov Today; 2017 Jun; 22(6):952-959. PubMed ID: 28435061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.
    Krishnamurthy S; Ke X; Yang YY
    Nanomedicine (Lond); 2015 Jan; 10(1):143-60. PubMed ID: 25597774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can nanomedicines kill cancer stem cells?
    Zhao Y; Alakhova DY; Kabanov AV
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
    Gao J; Li W; Guo Y; Feng SS
    Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell theory: therapeutic implications for nanomedicine.
    Wang K; Wu X; Wang J; Huang J
    Int J Nanomedicine; 2013; 8():899-908. PubMed ID: 23467584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
    Li L; Ni R; Zheng D; Chen L
    Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
    Malhi S; Gu X
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms.
    Kanwar JR; Samarasinghe RM; Kamalapuram SK; Kanwar RK
    Mini Rev Med Chem; 2017; 17(18):1688-1695. PubMed ID: 26891936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells.
    Oswald JT; Patel H; Khan D; Jeorje NN; Golzar H; Oswald EL; Tang S
    Curr Pharm Des; 2020; 26(17):2057-2071. PubMed ID: 32250211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells.
    Yao HJ; Zhang YG; Sun L; Liu Y
    Biomaterials; 2014 Nov; 35(33):9208-23. PubMed ID: 25115788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers.
    Mokhtarzadeh A; Hassanpour S; Vahid ZF; Hejazi M; Hashemi M; Ranjbari J; Tabarzad M; Noorolyai S; de la Guardia M
    J Control Release; 2017 Nov; 266():166-186. PubMed ID: 28941992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of cancer stem cells in cancer drug development and drug delivery.
    Chow EK
    J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells, metabolism, and therapeutic significance.
    Yang M; Liu P; Huang P
    Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells.
    Kim SS; Rait A; Rubab F; Rao AK; Kiritsy MC; Pirollo KF; Wang S; Weiner LM; Chang EH
    Mol Ther; 2014 Feb; 22(2):278-291. PubMed ID: 24113515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.